Fortress Biotech, Inc. (FBIO)

Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	255.84	79.38	57.26	80.93	178.27	305.74
Cash & Short-Term Investments	255.84	79.38	57.26	80.93	178.27	305.74
Cash Growth	180.10%	38.63%	-29.24%	-54.60%	-41.69%	31.02%
Accounts Receivable	24.99	29.78	10.23	15.22	28.21	23.11
Other Receivables	0.52	0.16	0.17	0.17	0.14	0.68
Total Trade Receivables	25.51	29.94	10.4	15.39	28.35	23.79
Inventory	9.29	9.62	14.43	10.21	14.16	9.86
Other Current Assets	4.84	4.9	8.28	10.5	9.66	7.07
Total Current Assets	295.48	123.84	90.37	117.02	230.43	346.46
Net Property, Plant & Equipment	14.25	14.82	17.12	23.5	33.01	34.07
Other Intangible Assets	26.48	27.61	31.86	20.29	27.2	12.55
Long-Term Investments	18.71	17.66	2.59	-	-	-
Other Long-Term Assets	1.96	1.62	2.28	6.72	3.66	3.42
Total Assets	356.87	185.55	144.22	167.53	294.3	396.5

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	92.99	47.13	65.5	73.56	97.45	90.66
Short-Term Debt	2.5	-	-	-	2.95	0.81
Current Portion of Long-Term Debt	-	-	-	3.93	2.05	-
Current Portion of Leases	2.22	2.13	2.62	2.52	2.45	2.1
Unearned Revenue	-	-	-	-	-	2.61
Other Current Liabilities	5.69	0.49	3.28	4.89	22.82	4.86
Total Current Liabilities	103.39	49.74	71.4	84.91	127.72	101.04
Long-Term Debt	36.88	52.42	57.96	60.86	91.73	42.94
Long-Term Leases	12.03	12.67	14.75	18.28	21.57	20.99
Other Long-Term Liabilities	2.2	8.53	1.76	1.89	3.26	5.66
Total Long-Term Liabilities	51.11	73.62	74.47	81.03	116.56	69.58
Total Liabilities	154.5	123.37	145.87	165.94	244.28	170.63

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Preferred Stock	0	0	0	0	0	0
Common Stock	0.03	0.03	0.03	0.02	0.01	0.1
Additional Paid-in Capital	785.85	783.89	763.57	717.4	675.94	656.03
Retained Earnings	-623.68	-734.05	-740.87	-694.87	-634.23	-547.46
Total Common Shareholders' Equity	162.21	49.87	22.74	22.54	41.72	108.67
Minority Interest	40.17	12.31	-24.38	-20.96	8.3	117.2
Shareholders' Equity	202.37	62.18	-1.64	1.59	50.03	225.88
Total Liabilities & Equity	356.87	185.55	144.22	167.53	294.3	396.5

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	53.63	67.22	75.34	85.59	120.75	66.84
Net Cash (Debt)	202.21	12.17	-18.07	-4.67	57.52	238.9
Net Cash Growth	1082.33%	-	-	-	-75.92%	52.23%
Net Cash Per Share	6.69	0.44	-0.87	-0.57	9.71	43.86
Book Value	162.21	49.87	22.74	22.54	41.72	108.67
Book Value Per Share	5.37	1.79	1.09	2.78	7.04	19.95
Tangible Book Value	135.73	22.27	-9.13	2.26	14.52	96.12
Tangible Book Value Per Share	4.49	0.80	-0.44	0.28	2.45	17.65

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error